A biotechnology company founded by professors at the University of California Davis has leased a 9,000-square-foot office in North Sacramento.
BCD Bioscience, a 2019 startup, is taking space in a 90,000-square-foot building at 2535 Capitol Oaks Drive.
“We are very excited about our new location. It is perfect for our growth from a research company into a fiber ingredient supplier,” said BCD CEO Steven Watkins, in a news release from Reno-based Basin Street Properties, which owns the building.
Watkins said BCD was attracted to the location because of its proximity to Davis, Sacramento and Sacramento International Airport.
The company’s former headquarters had been a small office in downtown Davis, according to filings with the Securities and Exchange Commission. Office space in Davis is notoriously in short supply.
BCD has developed proprietary techniques to transform food-grade substances into products at the cellular level which may have nutritional and immune benefits, according to its website. It's also building a library of natural sources from which to derive those products and how to do so. On its website, the company says that BCD stands for "Better Carbohydrate Design."
The company didn’t respond to an email from the Business Journal seeking comment.
BCD raised $4.8 million from investors in 2020 for carbohydrate research. It also raised money this year. As of this spring, the company had raised a total of $16.4 million, according to funding tracker site Crunchbase.
BCD uses mass spectrometry approaches to investigate chemical compositions of carbohydrates, which are the most abundant biomolecules on earth, according to its website. BCD is building a platform that allows potential partner companies or customers to get in-depth chemical compositions of carbohydrates, which can be sourced from vegetables, yeast, fruit, fungi, algae, plants and animal sources.
The Capitol Oaks Office Building is a Class A, four-story office building featuring free parking. Basin Street Properties bought the building in 2007. It must like the neighborhood, because earlier this year Basin Street Properties acquired four other nearby office buildings.
Scott Bennett of commercial real estate brokerage Colliers represented BCD Bioscience. Todd Eschelman and Jack Blackmon of Newmark represented Basin Street Properties.
